Literature DB >> 6308514

Muscle phosphoglycerate mutase (PGAM) deficiency: a second case.

N Bresolin, Y I Ro, M Reyes, A F Miranda, S DiMauro.   

Abstract

Muscle phosphoglycerate mutase (PGAM) activity was markedly decreased (6% of the normal mean) in a 17-year-old girl with recurrent myoglobinuria after intense exercise. Muscle biopsy showed increased PAS stain; glycogen concentration was twice normal. Studies of anaerobic glycolysis in vitro showed decreased lactate production with glycogen, and with all hexose phosphate glycolytic intermediates, which was corrected by addition of purified PGAM to the reaction mixtures. A defect of the M subunit of PGAM was documented by electrophoretic, heat lability, and mercury inhibition studies. Intermediate PGAM activities (39 and 50% of normal) were found in muscle biopsies from the patient's asymptomatic parents. These data confirm the clinical, morphologic, and biochemical features described in the first patient with PGAM deficiency and suggest autosomal-recessive transmission of the trait.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308514     DOI: 10.1212/wnl.33.8.1049

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

2.  Myopathies due to enzyme deficiencies.

Authors:  F Cornelio; S Di Donato
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

3.  The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency.

Authors:  S Tsujino; S Shanske; S Sakoda; G Fenichel; S DiMauro
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

4.  Novel heterozygous mutations in the PGAM2 gene with negative exercise testing.

Authors:  M Sidhu; L Brady; G D Vladutiu; M A Tarnopolsky
Journal:  Mol Genet Metab Rep       Date:  2018-10-09

5.  Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: biochemistry, muscle culture and 31P-MR spectroscopy.

Authors:  G Vita; A Toscano; N Bresolin; G Meola; F Fortunato; A Baradello; B Barbiroli; C Frassineti; P Zaniol; C Messina
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.